Higher Stroke Risk Associated With Estrogen Contraceptives in Women With Migraine
Taking estrogen-containing contraceptives increases risk for stroke in women with migraine with aura.
For individuals with migraine frequency of 4 to 14 episodes a month, prophylactic medications and analgesics are required.
Allergan has reported positive results from the first of 2 Phase 3 trials for ubrogepant for the treatment of migraine.
The FDA has granted GammaCore 510(k) expanded clearance to treat migraine related pain.